Novartis AG is 281.4x more valuable than Ventyx Biosciences, Inc. by market capitalization ($282.64 B vs $1.00 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | VTYX | NVS |
|---|---|---|
| Market cap | $1.00 B | $282.64 B |
| US-listed rank | #2633 | #47 |
| Net income (latest FY) | -$135.12M | - |
| SEC filings | 495 | 947 |
Novartis AG is 281.4x more valuable than Ventyx Biosciences, Inc. by market capitalization ($282.64 B vs $1.00 B).
Full pages: Ventyx Biosciences, Inc. and Novartis AG, or browse the full rankings.